Thousand Oaks Biopharmaceuticals

company

About

Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds.

  • 251 - 500

Details

Last Funding Type
Angel
Industries
Biopharma,Biotechnology,Health Care
Founded date
Mar 1, 2017
Number Of Employee
251 - 500
Operating Status
Active

Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. The company's technologies provide integrated control solutions, including the use of technical expertise to optimize the process and increase protein expression to reduce production scale, providing bio-pharmaceutical companies with personalized, chemical-defined cell culture media, formula production, technical support and ancillary services.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
¥700M
Thousand Oaks Biopharmaceuticals has raised a total of ¥700M in funding over 2 rounds. Their latest funding was raised on Mar 10, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 10, 2021 Series C ¥400M 1 Detail
Jul 24, 2020 Series B 1 Detail
Jun 1, 2020 Series Unknown 1 Detail
Jan 1, 2019 Series A ¥300M 2 Detail
Jan 2, 2017 Angel 1 Blue Bay Science Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
5
Thousand Oaks Biopharmaceuticals is funded by 5 investors. Jinshi Investment and Huaxu Investment are the most recent investors.
Investor Name Lead Investor Funding Round
Jinshi Investment Series C
Huaxu Investment Series B
Yinglian Health Fund Series Unknown
Blue Bay Science Capital Series A
TenYall & Sumin Series A